Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Viyaasan Mahalingasivam

BMedSci MBBS MRCP MSc

Research Fellow

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Jump to: Affiliations Research Publications

I graduated from Barts and The London School of Medicine & Dentistry in 2010 and subsequently completed training in Nephrology and General Internal Medicine on the North Thames rotation in London. I undertook a Masters degree in Epidemiology at the London School of Hygiene & Tropical Medicine in 2017-19, and returned to commence an NIHR Doctoral Research Fellowship in 2021. I continue to do clinical work as an honorary consultant nephrologist at Barts Health NHS Trust.

Affiliations
Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Research

I work with routinely-collected electronic health records and am investigating the impact of COVID-19 on kidney disease.

Research Area
Clinical databases
Electronic health records
Discipline
Epidemiology
Medicine
Disease and Health Conditions
Cardiovascular disease
Diabetes
Kidney disease
Non-communicable diseases
Coronavirus

Selected Publications
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.
Green ACA; Curtis HJ; Higgins R; Nab L; Mahalingasivam V; Smith RM; Mehrkar A; Inglesby P; Drysdale H; DeVito NJ
2023
BMJ Medicine
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT)
Herrett E; Tomlin K; Lin L-Y; Tomlinson LA; Jit M; Briggs A; Marks M; Sandmann F; Parry J; Bates C
2023
BMJ Open
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
OpenSAFELY Collaborative; Parker EP; Tazare J; Hulme WJ; Bates C; Carr EJ; Cockburn J; Curtis HJ; Fisher L; Green AC
2023
BMJ Open
Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations.
Carrero JJ; Fu EL; Vestergaard SV; Jensen SK; Gasparini A; Mahalingasivam V; Bell S; Birn H; Heide-Jørgensen U; Clase CM
2022
Kidney international
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY.
OpenSAFELY Collaborative; Green A; Curtis H; Hulme W; Williamson E; McDonald H; Bhaskaran K; Rentsch C; Schultze A; MacKenna B
2022
BMC medicine
Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
The OpenSAFELY Collaborative; Parker EPK; Horne EMF; Hulme W; Tazare J; Zheng B; Carr E; Loud F; Lyon S; Mahalingasivam V
2022
medRxiv
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study
The OpenSAFELY Collaborative; Parker EPK; Tazare J; Hulme W; Bates C; Beale R; Carr E; Cockburn J; Curtis H; Fisher L
2022
medRxiv
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
Zheng B; Green ACA; Tazare J; Curtis HJ; Fisher L; Nab L; Schultze A; Mahalingasivam V; Parker EPK; Hulme WJ
2022
BMJ (Clinical research ed.)
See more Publications
Viyaasan Mahalingasivam

Contact

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom